PRNP and synucleinopathy: There are also opposing studies on PrPC binding of α-synuclein (α-syn) oligomers in Parkinson’s disease (PD) and other synucleinopathies, opening the debate on the role of PrPC in toxicity of α-synuclein [30,31,32,33].